Oncology Precision Medicine Market Analysis, Size, Share, and Forecast 2031
The Oncology Precision Medicine Market in 2023 is US$ 105.96 billion, and is expected to reach US$ 225.82 billion by 2031 at a CAGR of 9.90%.
FutureWise Research published a report that analyzes Oncology Precision Medicine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Oncology Precision Medicine research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Oncology Precision Medicine Market Sample
Oncology Precision Medicine Market Segmentation:
By Application
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Other
By Ecosystem
- Applied Sciences
- Genomics
- Global Oncology Precision Medicine Genomics Market (by Technology)
- Polymerase Chain Reaction (PCR)
- Precision Medicine Next-Generation Sequencing (PM NGS)
- Genome Editing
- Other Technologies
- Pharmacogenomics
- Other Applied Sciences
- Precision Diagnostics
- Molecular Diagnostics (MDx)
- Medical Imaging
- Digital Health and Information Technology
- Clinical Decision Support Systems (CDSS)
- Big Data Analytics
- IT Infrastructure
- Genomics Informatics
- In-Silico Informatics
- Mobile Health
- Precision Therapeutics
- Clinical Trials
- Cell Therapy
- Drug Discovery and Research
- Gene Therapy
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Key Market Players:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Almac Group Ltd.
- ANGLE plc
- Asuragen, Inc.
- AstraZeneca PLC
- Bristol Myers Squibb
- bioMérieux SA.
- BGI Group
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc.
- Gilead Sciences, Inc.
- Illumina, Inc
- Konica Minolta, Inc.
- Laboratory Corporation of America Holdings
- MDx Health, Inc.
- Myriad Genetics, Inc.
- Novartis AG
- Opko Health,Inc.
- Pacific Biosciences of California, Inc.
- Teva Pharmaceutical Industries Ltd.
- Thermofisher Scientific
- QIAGEN
- Quest Diagnostics
Please visit full report of the Oncology Precision Medicine market @ Visit Oncology Precision Medicine Market
Competitive Landscape:
· Tier one players - market players with a significant share of the market
· Tier two players
· Players with rapid growth
· New Entries
FutureWise Key Takeaways:
• Prospects for growth
• Analysis of SWOT
• Key trends
• Key Data-points affecting market growth
Objectives of the Study:
• To provide report with an in-depth analysis of the Oncology Precision Medicine Market By Application, By Ecosystem and By Region
• To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
• Analysis and forecasting of micro-markets, as well as the scope of the market.
• To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
• To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Flexible Delivery Model:
• With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
• Customization services are included with the purchase of any license type of report.
• Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian